A Korean company developing a big data and artificial intelligence based non-invasive medical device for measuring blood glucose and blood pressure seeks foreign investors under financial agreement

[ad_1]
A Korean company has been developing a non-invasive blood glucose and blood pressure medical device using a ballistocardiogram measuring sensor. This company is also employing technologies of artificial intelligence and big data analysis to the developed medical device to increase data accuracy and prediction of personal health information. In order to do this, the company is looking for foreign investors under financial agreement.

[ad_2]